Inventurus Knowledge Solutions IPO Details, Financials, Valuation & Peers
Explore Inventurus Knowledge Solutions IPO details, including IPO dates, financial statements, valuation, peer comparison and more.

Overview
Inventurus Knowledge Solutions Limited (IKS) is a technology-enabled healthcare solutions provider, offering a comprehensive care enablement platform to physician enterprises in the US, Canada, and Australia, with a primary focus on the US market. IKS supports outpatient and inpatient care organizations by enabling superior clinical outcomes, enhancing operational efficiencies, and optimizing revenue cycle management. The company's solutions alleviate administrative and operational burdens, allowing healthcare enterprises to focus on delivering better and more cost-effective patient care. With an asset-light global workforce and cutting-edge technology platforms, IKS partners with 778 healthcare organizations, including notable clients such as Mass General Brigham Inc. and Texas Health Care PLLC, as of September 30, 2024.
Key Points:
- Core Offering:
- Comprehensive care enablement platform tailored for outpatient and inpatient healthcare enterprises.
- Services include clinical documentation, patient scheduling assistance, clinical data management, and digital health solutions.
- Market Reach:
- Serves 778 healthcare organizations globally, including health systems, academic medical centers, multi- and single-specialty medical groups, and ancillary healthcare providers.
- Strong presence in the US, Canada, and Australia with a workforce of over 13,528 employees, including 2,612 clinically trained staff.
- Value Proposition:
- Reduces administrative burdens for physicians through structured clinical documentation, automated solutions, and patient data management.
- Optimizes revenue cycle management by enhancing payment collection, minimizing bad debts, and improving insurance claim processes.
- Supports risk-bearing healthcare organizations in delivering value-based care with solutions for population health management, care gap identification, and preventive care.
- Digital Health Transformation:
- Offers a Unifying Data Platform (UDP) that aggregates data from disparate billing systems and electronic health records (EHR) to create centralized, actionable insights.
- Enables healthcare organizations to modernize their technology systems without requiring costly migrations.
- Client Impact:
- Helps healthcare organizations improve clinical outcomes, achieve cost-efficiency, and transition to value-based care models.
- Empowers healthcare providers to deliver patient-centered care while mitigating physician burnout and enhancing operational sustainability.
Objects of the Issue
- To carry out the Offer for Sale of up to 18,795,510 Equity Shares of face value of ₹ 1 each by the Selling Shareholders
- Achieve the benefits of listing the Equity Shares on the Stock Exchanges
IPO Details
Discover essential information crucial for understanding an IPO, including the Price Band, Fresh Issue, Offer For Sale, Total IPO Size and more. Explore these key details to gain insight into the company's public offering.
Fields | Details |
---|---|
IPO Dates | 12 Dec - 16 Dec 2024 |
IPO Price Band | ₹1,265 - ₹1,329 per share |
Fresh Issue | NIL |
Offer For Sale | 18,795,510 shares |
Total IPO Size | ₹2,497.92 crore |
Face Value | ₹1 |
Listing On | BSE, NSE |
IPO Timeline
Explore important dates like IPO opening, closing, listing and others, outlining the journey of the Public Offering. This will help you grasp the entire IPO journey effortlessly.
Event | Date |
---|---|
IPO Opening Date | 12 Dec 2024 |
IPO Closing Date | 16 Dec 2024 |
Basis Of Allotment | 17 Dec 2024 |
Refunds | 18 Dec 2024 |
Demat Transfer | 18 Dec 2024 |
IPO Listing Date | 19 Dec 2024 |
Financial Statements
Explore a comprehensive financial data table showcasing key metrics including revenue, expenses, net income, and others. Gain valuable insights about the company's financial performance at a glance, facilitating informed decision-making and strategic planning for subscribing to the IPO.
Period Ended | 31st March 2022 | 31st March 2023 | 31st March 2024 | Sep 2024 |
---|---|---|---|---|
Total Income | 784.47 | 1,060.16 | 1,857.94 | 1,294.61 |
Total Expenses | 496.21 | 669.91 | 1,416.27 | 1,028.57 |
Net Profit/Loss | 232.97 | 305.23 | 370.49 | 208.58 |
NPM (*) | 30.51 | 29.60 | 20.38 | 16.26 |
Total Assets | 787.52 | 988.31 | 3,027.52 | 2,790.52 |
Total Liabilities | 140.45 | 159.67 | 1,869.66 | 1,413.42 |
* NPM represents the net profit margin, calculated as a percentage. All other figures are presented in crore (₹cr)
Valuation
Uncover significant valuation metrics such as EPS (Earnings Per Share), ROE (Return on Equity), ROCE (Return on Capital Employed), D/E Ratio (Debt-to-Equity Ratio), Current Ratio, and EBITDA Margin. These key indicators offer insights into the company's financial standing and performance, aiding in informed investment decisions.
Period Ended | 31st March 2022 | 31st March 2023 | 31st March 2024 | Sep 2024 |
---|---|---|---|---|
EPS | 14.04 | 18.13 | 22.15 | 12.35 |
ROE (%) | 36.00 | 36.83 | 32.00 | 15.15 |
ROCE (%) | 49.82 | 49.43 | 31.56 | 13.79 |
D/E Ratio | NA | 2.06 | -0.06 | NA |
Current Ratio | 5.56 | 6.07 | 1.14 | 1.22 |
EBITDA MARGIN (%) | 36.33 | 34.95 | 28.62 | 27.99 |
* Compiled from DRHP/RHP for valuation purposes.
Peer Comparison
No listed peers available for comparison.
IPO Reservation
Investor Type | Shares Offered |
---|---|
Qualified Institutional Buyer (QIB) | Not less than 75% |
Non-Institutional Investor (NII/HNI) | Not less than 15% |
Retail Individual Investor (RII) | Not less than 10% |
Subscription Data from NSE and BSE
Investor Type | Subscribed |
---|---|
Qualified Institutional Buyer (QIB) | 80.64 |
Non-Institutional Investor (NII/HNI) | 23.25 |
Retail Individual Investor (RII) | 14.55 |
Total | 52.68 |
* All figures represent multiples of the subscription. Check subscriptions for other ongoing issues here.
IPO Registrar
MUFG Intime India Private Limited (Formerly known as Link Intime India Private Limited)
Phone: + 91 810 811 4949
Email: ipo.helpdesk@linkintime.co.in
Website: https://linkintime.co.in/
Company Promoters
- SACHIN GUPTA
- REKHA JHUNJHUNWALA
- ARYAMAN JHUNJHUNWALA DISCRETIONARY TRUST
- ARYAVIR JHUNJHUNWALA DISCRETIONARY TRUST
- NISHTHA JHUNJHUNWALA DISCRETIONARY TRUST
Lead Managers
- ICICI Securities Limited
- Jefferies India Private Limited
- JM Financial Limited
- J.P. Morgan India Private Limited
- Nomura Financial Advisory and Securities (India) Private Limited
Company Address
Inventurus Knowledge Solutions Limited
Building No. 5 & 6, Unit No. 801, 8th Floor, Mindspace SEZ, Thane Belapur Road, Airoli, Navi Mumbai, Thane, Maharashtra – 400 708, India
Phone: +91 22 3964 3205
Email: company.secretary@ikshealth.com
Website: https://www.ikshealth.com
FAQs
- What is the issue size of the Inventurus Knowledge Solutions IPO?The Inventurus Knowledge Solutions IPO has an issue size of ₹2,497.92 crore. This includes a fresh issue of NIL and an offer for sale (OFS) of 18,795,510 shares.
- What is the price band of the Inventurus Knowledge Solutions IPO?The price band for the Inventurus Knowledge Solutions IPO is ₹1,265 - ₹1,329 per share.
- What are the bidding dates for the Inventurus Knowledge Solutions IPO?The Inventurus Knowledge Solutions IPO will open for bidding on 12 Dec 2024 and close on 16 Dec 2024.
- What is the allotment date for the Inventurus Knowledge Solutions IPO?The allotment date for the Inventurus Knowledge Solutions IPO is 17 Dec 2024.
- What is the minimum lot size and investment required for the Inventurus Knowledge Solutions IPO?The minimum lot size for the Inventurus Knowledge Solutions IPO is 11 shares and the minimum investment required is ₹14,619.
- What is the listing date for the Inventurus Knowledge Solutions IPO?The listing date for the Inventurus Knowledge Solutions IPO is 19 Dec 2024.
- What is the Inventurus Knowledge Solutions IPO grey market premium?The grey market premium (GMP) for the Inventurus Knowledge Solutions IPO is currently at ₹421, with an expected listing gain of approximately 31.68%. Remember, the grey market premium is not an official indicator, but it reflects market perception and demand for the IPO shares.